Le Parlement européen a entamé la révision de la stratégie pharmaceutique pour l’Europe au premier trimestre 2023. La nouvelle législation luttera notamment contre la fragmentation de la recherche et du développement en matière de santé dans l’Union européenne, le manque de transparence et l’écart entre les investissements publics et les résultats cliniques obtenus. Parmi les solutions envisagées: la création d’une infrastructure biomédicale européenne de grande envergure, mais aussi une série de stratégies ciblées qui coordonneront mieux la recherche en matière de santé dans l’Union et accorderont la priorité aux maladies contre lesquelles il n’existe pas de traitement satisfaisant.

Nouvelle stratégie pharmaceutique pour l’Europe - français

European food safety policy aims are twofold: to protect human health and consumers’ interests, and to foster the smooth operation of the European single market.

The EU thus ensures that control standards are established and adhered to in the areas of feed and food-product hygiene, animal health, plant health and the prevention of food contamination from external substances. The Union also regulates labelling for food and feed products.

In the wake of a series of human food and animal feed crises, EU food safety policy underwent substantial reform in the early 2000s. The ‘Farm to Fork’ approach was defined, guaranteeing a high level of safety at all stages of the production and distribution process for all food products marketed within the EU, whether produced within the EU or imported from third countries.

Food safety

Vaccines are a key part of a long-term strategy to bring SARS-CoV-2 under control. It is essential to roll out vaccination rapidly to protect as many people as possible and to lower the opportunities for the virus to evolve further. Any vaccine must be authorised by the European Medicines Agency (EMA).

The European Commission has secured up to 4.4 billion doses of COVID-19 vaccines so far - and negotiations are underway for additional doses. However, countries are facing different challenges around the disinformation or vaccine acceptance. The European Parliament is trying to keep an eye on the purchase and safety of these vaccines. During June plenary the EP adopted a resolution calling for COVID-19 vaccine patent waiver. Parliament proposed negotiations start for a temporary waiver of the WTO TRIPS Agreement on patents to improve global access to affordable COVID-19-related medical products and to address global production constraints and supply shortages. The EP approved also the Digital Green Certificate to facilitate the safe free movement of citizens within the EU during the pandemic.

EU Vaccine Strategy

The EU Digital COVID Certificate aims to facilitate safe free movement inside the EU during the COVID-19 pandemic.The certificate should&nbsp;be available in either digital or paper format. It attests that a person has been vaccinated against coronavirus or has a recent negative test result or has recovered from the infection.

&nbsp;A common EU framework is&nbsp;allowing member states to issue certificates that will then be accepted in other EU countries. The EU Digital Covid Certificate regulation should be&nbsp;in place for 12 months. The certificate should&nbsp;not be a precondition to exercise the right to free movement and is&nbsp;not&nbsp;considered a travel document.

Member states should not impose additional travel restrictions in response to the COVID-19 pandemic, such as quarantine, self-isolation or testing, “unless they are necessary and proportionate to safeguard public health”. Member states must accept vaccination certificates issued in other member states for persons inoculated with a vaccine authorised for use in the EU by the European Medicines Agency (EMA).

It is&nbsp;up to the member states to decide whether they also accept vaccination certificates that have been authorised by other Member States following national authorisation procedures or for vaccines listed by the World Health Organisation (WHO) for emergency use. The Regulation entered&nbsp;into force on&nbsp;1 July 2021.
 Parliament and EU member states’ negotiators have agreed to keep the EU Digital COVID Certificate framework in place for another year, until June 2023

EU Digital COVID certificate

Virginijus Sinkevičius, born on 4 November 1990 in Vilnius, is a Lithuanian politician. Commissioner-designate for Environment, Oceans and Fisheries.

After the hearing by the Committee on Fisheries (PECH) and the Committee on the Environment, Public Health and Food Safety (ENVI) of the European Parliament, the committees prepare an evaluation letter on the candidate.

Hearing of Virginijus SINKEVIČIUS, Commissioner-designate

Frans Timmermans, born on 6 May 1961 in Maastricht, is a Dutch politician. Timmermans is Executive Vice-President and Commissioner designate for European Green Deal.

After the hearing by the Committee on Environment, Public Health and Food Safety (ENVI) of the European Parliament, the committee prepares an evaluation letter on the candidate. Parliament is expected to vote on the new Commission as a whole on 23 October.

Hearing of Frans TIMMERMANS, Executive Vice-President-designate

Stella Kyriakides, born on 10 March 1956 in Nicosia, is a Cypriot psychologist and politician.

After the hearing by the Committee on Environment, Public Health and Food Safety (ENVI) of the European Parliament, the committee prepares an evaluation letter on the candidate. Parliament is expected to vote on the new Commission as a whole on 23 October.

Hearing of Stella KYRIAKIDES, Commissioner-designate, Health

Teresa RIBERA RODRÍGUEZ was the Third Deputy Spanish Prime Minister and Minister for the Ecological Transition and the Demographic Challenge. She is now Executive Vice-President-designate of the European Commission for a Clean, Just and Competitive Transition, for the von der Leyen Commission II.

Confirmation hearing of Teresa RIBERA RODRÍGUEZ, Executive Vice-President designate, Clean, Just and Competitive Transition

Stéphane Séjourné was a Member of the European Parliament from 2019 to 2024, Chair of the Renew Europe Group of the European Parliament in 2021 and French Minister for Europe and Foreign Affairs in 2024. He is now Executive Vice-President-designate of the European Commission for Prosperity and Industrial Strategy, for the von der Leyen Commission II.

Confirmation hearing of Stéphane SÉJOURNÉ, Executive VIce-President designate, Prosperity and Industrial Strategy

Wopke Hoekstra was Dutch Minister for Finance from 2017 to 2022, Dutch Deputy Prime Minister and Minister for Foreign Affairs from 2022 to 2023 and European Commissioner for Climate Action and acting Commissioner for Transport in the von der Leyen Commission I. He is now European Commissioner-designate for Climate, Net Zero and Clean Growth, for the von der Leyen Commission II.

Confirmation hearing of Wopke HOEKSTRA, Commissioner-designate for Climate, Net Zero and Clean Growth

Olivér Várhely was European Commissioner for Neighbourhood and Enlargement in the von der Leyen Commission I. He is now European Commissioner-designate for Health and Animal Welfare, for the von der Leyen Commission II.

Confirmation hearing of Olivér VÁRHELYI, Commissioner-designated, Health and Animal Welfare

Hadja Lahbib was Belgian Minister for Foreign Affairs, European Affairs and Foreign Trade, and the Federal Cultural Institutions since 2022. She is now European Commissioner-designate for Preparedness and Crisis Management, and European Commissioner-designate for Equality, for the von der Leyen Commission II.

Confirmation hearing of Hadja LAHBIB, Commissioner-designate, Preparedness and Crisis Management

Jessika Roswall was Swedish Minister for EU Affairs since 2022. She is now European Commissioner-designate for Environment, Water Resilience and a Competitive Circular Economy, for the von der Leyen Commission II.

Confirmation hearing of Jessika ROSWALL, Commissioner-designate, Environment, Water Resilience and a Competitive Circular Economy

ENVI IMCO - Trilogue on Green Claims Directive

ENVI - public hearing on ' The way to a European Water Resilience Strategy - An EU Blue Deal '

ENVI  Extraordinary meeting - Exchange of views with Paulina Hennig-Kloska, Minister of Climate and Environment, Polish Council Presidency

ENVI AGRI joint committees - Public Hearing - Forest Monitoring for resilient European Forests

ENVI - Bilateral meeting with the Polish Presidency of the Council

IMCO - Bilateral meeting with the Polish Presidency of the Council

ENVI - Presentation of the responsibilities and activities of the following agencies under ENVI competence - Exchange of views with Dr. Yukiko Nakatani, WHO Assistant Director-General, on Antimicrobial Resistance

ENVI - Presentation of the responsibilities and activities of the following agencies under ENVI competence -  Presentation of the responsibilities and activities of the following agencies under ENVI competence

AGRI ENVI joint committee meeting

ENVI ECON ITRE -  Confirmation hearing of Teresa RIBERA RODRÍGUEZ, European Commissioner-designate for Clean, Just and Competitive Transition - Press point

ENVI ECON ITRE -  Confirmation hearing of Teresa RIBERA RODRÍGUEZ, European Commissioner-designate for Clean, Just and Competitive Transition

ITRE IMCO ENVI ECON -  Confirmation hearing of Stéphane SÉJOURNÉ, European Commissioner-designate for Prosperity and Industrial Strategy - Press point

ITRE IMCO ENVI ECON -  Confirmation hearing of Stéphane SÉJOURNÉ, European Commissioner-designate for Prosperity and Industrial Strategy

ENVI ITRE ECON - Confirmation hearing of Wopke Bastiaan HOEKSTRA, European Commissioner-designate for Climate, Net-Zero and Clean Growth.- Press point

ENVI ITRE ECON - Confirmation hearing of Wopke Bastiaan HOEKSTRA, European Commissioner-designate for Climate, Net-Zero and Clean Growth

ENVI AGRI -  Confirmation hearing of Olivér VÁRHELYI, European Commissioner-designate for Health and Animal Welfare

DEVE FEMM ENVI - Confirmation hearing of Hadja LAHBIB, European Commissioner-designate for Preparedness and Crisis Management Equality - Press Point

DEVE FEMM ENVI - Confirmation hearing of Hadja LAHBIB, European Commissioner-designate for Preparedness and Crisis Management Equality

In the European Parliament in Brussels, the Committee on Environment, Public Health and Food Safety (ENVI) debates with Frans TIMMERMANS, Executive Vice-President of the EC and European Commissioner for the European Green Deal, on the 2030 Climate Target Plan, which includes a Communication on “Stepping up Europe's 2030 Climate Ambition” and an Impact Assessment. The committee already adopted its position on the Climate Law Regulation, increasing the 2030 reduction target to 60%. Parliament will vote on the draft law in the 5-8 October plenary.

Stepping up Europe’s 2030 climate ambition: extracts from the debate

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 1 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Presentation by the speakers. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Presentation by the speakers.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 2 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 2/ 2 Q&A with ENVI and ITRE Members.

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Conclusion and closing remarks by Pascal CANFIN (Renew, FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Conclusion and closing remarks by the Chairs

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Welcome and opening remarks by Pascal CANFIN (Renew,FR), ENVI Chair and by Cristian-Silviu BUŞOI (EPP,RO), ITRE Chair. This transcription speech is the result of an automatic process. Check against delivery.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. Welcome and opening remarks by the Chairs

Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) debate with Hans KLUGE, WHO Regional Director for Europe, during an exchange of views on the fight against COVID-19 and the global response to it. Increased coordination and cooperation at global level are crucial to better prevent and tackle pandemics. MEPs debate - part 2 followed by the response by Hans KLUGE, WHO Regional Director for Europe

Exchange of views with Hans KLUGE, WHO Regional Director for Europe: MEPs debate (part 2) and response by Hans KLUGE

Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) debate with Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO), during an exchange of views on the fight against COVID-19 and the global response to it. Increased coordination and cooperation at global level are crucial to better prevent and tackle pandemics. Pascal CANFIN (RE, FR), ENVI Chair, makes the opening remarks followed by the opening statement by Tedros Adhanom Ghebreyesus.

Exchange of views with Tedros Adhanom Ghebreyesus, WHO Director General: opening statement by Pascal CANFIN (RE, FR), ENVI Chair, and Tedros Adhanom Ghebreyesus

Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) debate with Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO), during an exchange of views on the fight against COVID-19 and the global response to it. Increased coordination and cooperation at global level are crucial to better prevent and tackle pandemics. MEPs debate - part 1followed by the response by Tedros Adhanom Ghebreyesus.

Exchange of views with Tedros Adhanom Ghebreyesus, WHO Director General: MEPs debate (part 1) and response by Tedros Adhanom Ghebreyesus

The Committee on the Environment, Public Health and Food Safety (ENVI) debates with Stella KYRIAKIDES, European Commissioner for Health and Food Safety, on an EU Strategy for COVID-19 vaccines. It proposes a joint EU approach to accelerate the development of vaccines, in the European Parliament in Brussels.

EU Strategy for COVID-19 vaccines: extracts from the exchange of views with Stella KYRIAKIDES, European Commissioner for Health and Food Safety

The Committee on Environment and Public Health (ENVI) discuss how to ensure fast approval of safe COVID-19 vaccines and treatments in the EU with Guido RASI, Executive Director of the European Medicines Agency (EMA), in the European Parliament in Brussels.

EMA’s activities on COVID-19 and prospects for the future: extracts from the exchange of views with Guido RASI, Executive Director of European Medicines Agency (EMA)

The Committee on the Environment, Public Health and Food Safety (ENVI) exchange of views with Frans TIMMERMANS, Executive Vice-President of the European Commission in charge of the European Green Deal, in the European Parliament in Brussels. Arrival and opening. Most members and also Mr Timmermans were connected via remote conferencing system, in relation to the ongoing corona restrictions.

Exchange of views with Frans TIMMERMANS, Executive Vice-President of the European Commission in charge of the European Green Deal: Arrival and opening

The Committee on the Environment, Public Health and Food Safety (ENVI) discuss with the Commission how the EU is confronting, together with member states, the coronavirus Covid-19 in the European Parliament in Brussels. Statements by John RYAN, European Commission representative for DG SANTE, Jytte GUTELAND (S&D, SE), Jutta PAULUS (Greens/EFA, DE), Mairead MCGUINNESS (EPP, IE) and Andreas AMMON, Executive Director of the European Centre for Disease Prevention and Control (ECDC).

Update by the Commission on the COVID-19 (Coronavirus) situation: extracts from the exchange of views

Exchange of views with Greta THUNBERG, Climate activist on EU climate law and targets during a meeting of the EP Committee on the Environment, Public Health and Food Safety. This transcription speech is the he result of an automatic process. Check Against delivery.

EU climate law and targets: exchange of views. Opening statement by with Greta THUNBERG, Climate activist

Exchange of views with Greta THUNBERG, Climate activist on EU climate law and targets during a meeting of the EP Committee on the Environment, Public Health and Food Safety

EU climate law and targets: exchange of views with Greta THUNBERG, Climate activist. Atmosphere shots of the arrivals and opening by Pascal CANFIN, Chair of ENVI

During an extraordinary meeting, the Committee Environment, Public Health and Food Safety (ENVI) open to all MEPs, discuss the EU climate law and targets due to be announced the same day, with Greta THUNBERG, environmental activist, in the European Parliament in Brussels.

EU climate law and targets: extracts from the exchange of views with Greta THUNBERG, environmental activist

EU climate law and targets: exchange of views with Greta THUNBERG, Climate activist. MEPs debate

Greta THUNBERG, environmental activist, opens the extraordinary meeting of the Committee Environment, Public Health and Food Safety (ENVI) open to all MEPs, before discussing the EU climate law and targets due to be announced the same day, in the European Parliament in Brussels.

343 résultats